WO2006012468A3 - Detection of oligonuleotides by dual hybridization - Google Patents

Detection of oligonuleotides by dual hybridization Download PDF

Info

Publication number
WO2006012468A3
WO2006012468A3 PCT/US2005/025966 US2005025966W WO2006012468A3 WO 2006012468 A3 WO2006012468 A3 WO 2006012468A3 US 2005025966 W US2005025966 W US 2005025966W WO 2006012468 A3 WO2006012468 A3 WO 2006012468A3
Authority
WO
WIPO (PCT)
Prior art keywords
oligonuleotides
detection
oligonucleotides
compositions
detecting
Prior art date
Application number
PCT/US2005/025966
Other languages
French (fr)
Other versions
WO2006012468A2 (en
Inventor
David T Shima
Pericles Calia
Gregory S Robinson
John P Wing
Lori M Mullin
Lillian M Smith
Ervin Sinani
Original Assignee
Osi Eyetech Inc
David T Shima
Pericles Calia
Gregory S Robinson
John P Wing
Lori M Mullin
Lillian M Smith
Ervin Sinani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osi Eyetech Inc, David T Shima, Pericles Calia, Gregory S Robinson, John P Wing, Lori M Mullin, Lillian M Smith, Ervin Sinani filed Critical Osi Eyetech Inc
Priority to JP2007522778A priority Critical patent/JP2008507284A/en
Priority to EP05776987A priority patent/EP1776474A2/en
Publication of WO2006012468A2 publication Critical patent/WO2006012468A2/en
Publication of WO2006012468A3 publication Critical patent/WO2006012468A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides methods and compositions for detecting and/or quantifying modified nucleic acid oligonucleotides. These methods and compositions are useful for detecting and quantifying diagnostic and/or therapeutic synthetic modified oligonucleotides, such as aptamers, RNAi, siRNA, antisense oligonucleotides or ribozymes in a biological sample.
PCT/US2005/025966 2004-07-23 2005-07-21 Detection of oligonuleotides by dual hybridization WO2006012468A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2007522778A JP2008507284A (en) 2004-07-23 2005-07-21 Detection of oligonucleotides by dual hybridization
EP05776987A EP1776474A2 (en) 2004-07-23 2005-07-21 Detection of oligonuleotides by dual hybridization

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59050704P 2004-07-23 2004-07-23
US60/590,507 2004-07-23

Publications (2)

Publication Number Publication Date
WO2006012468A2 WO2006012468A2 (en) 2006-02-02
WO2006012468A3 true WO2006012468A3 (en) 2006-12-07

Family

ID=35786715

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/025966 WO2006012468A2 (en) 2004-07-23 2005-07-21 Detection of oligonuleotides by dual hybridization

Country Status (4)

Country Link
US (1) US7785784B2 (en)
EP (1) EP1776474A2 (en)
JP (1) JP2008507284A (en)
WO (1) WO2006012468A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1963531B1 (en) 2005-12-23 2011-09-21 Nanostring Technologies, Inc. Nanoreporters and methods of manufacturing and use thereof
US7833716B2 (en) 2006-06-06 2010-11-16 Gen-Probe Incorporated Tagged oligonucleotides and their use in nucleic acid amplification methods
EP1914317A1 (en) * 2006-10-21 2008-04-23 Biolytix AG A method for qualitative and quantitative detection of short nucleic acid sequences of about 8 to 50 nucleotides in length
WO2008052774A2 (en) * 2006-10-31 2008-05-08 Noxxon Pharma Ag Methods for detection of a single- or double-stranded nucleic acid molecule
US9714446B2 (en) * 2010-02-11 2017-07-25 Nanostring Technologies, Inc. Compositions and methods for the detection of small RNAs
WO2011162326A1 (en) * 2010-06-25 2011-12-29 株式会社日本遺伝子研究所 Rna strand storage solution
WO2015070173A1 (en) * 2013-11-08 2015-05-14 Isis Pharmaceuticals, Inc. Compounds and methods for detecting oligonucleotides
JP2017538437A (en) 2014-12-22 2017-12-28 シグマ−アルドリッチ・カンパニー・リミテッド・ライアビリティ・カンパニーＳｉｇｍａ−Ａｌｄｒｉｃｈ Ｃｏ．， ＬＬＣ Visualization of modified nucleotide and nucleic acid interactions in single cells
JP6744028B2 (en) * 2015-11-13 2020-08-19 Ｎｅｃソリューションイノベータ株式会社 Nucleic acid molecule binding to α-amylase and use thereof
US10772752B2 (en) 2016-11-04 2020-09-15 Obalon Therapeutics, Inc. Pressure control system for intragastric device
JP6977058B2 (en) * 2017-04-12 2021-12-08 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft A method for sequencing reactions using tagged nucleosides obtained via the Pictet-Spengler reaction
WO2020093308A1 (en) * 2018-11-08 2020-05-14 廖世奇 Composite target-tumor serum nucleic acid ligand detection method and kit
CN116355997A (en) * 2021-12-27 2023-06-30 迈克生物股份有限公司 Multiplex PCR reaction system

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995030139A1 (en) * 1994-04-29 1995-11-09 Perkin-Elmer Corporation System for real time detection of nucleic acid amplification products
EP1130113A1 (en) * 2000-02-15 2001-09-05 Johannes Petrus Schouten Multiplex ligation dependent amplification assay
US6426335B1 (en) * 1997-10-17 2002-07-30 Gilead Sciences, Inc. Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
US20020172946A1 (en) * 2000-02-07 2002-11-21 Jian-Bing Fan Nucleic acid detection methods using universal priming
EP1319718A1 (en) * 2001-12-14 2003-06-18 Keygene N.V. High throughput analysis and detection of multiple target sequences
US20040138163A1 (en) * 2002-05-29 2004-07-15 Mcswiggen James RNA interference mediated inhibition of vascular edothelial growth factor and vascular edothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849890A (en) * 1990-06-11 1998-12-15 Nexstar Pharmaceuticals, Inc. High affinity oligonucleotide ligands to chorionic gonadotropin hormone and related glycoprotein hormones
US5876924A (en) * 1994-06-22 1999-03-02 Mount Sinai School Of Medicine Nucleic acid amplification method hybridization signal amplification method (HSAM)
US5989823A (en) * 1998-09-18 1999-11-23 Nexstar Pharmaceuticals, Inc. Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
US6927024B2 (en) * 1998-11-30 2005-08-09 Genentech, Inc. PCR assay
US7125681B2 (en) * 2001-06-22 2006-10-24 Ludwig Institute For Cancer Research Methods for detection of disease-associated antibodies in urine
WO2003039404A2 (en) * 2001-11-09 2003-05-15 Eyetech Pharmaceuticals Methods for treating ocular neovascular diseases
WO2003092665A2 (en) * 2002-05-02 2003-11-13 Massachusetts Eye And Ear Infirmary Ocular drug delivery systems and use thereof
US20060167435A1 (en) * 2003-02-18 2006-07-27 Adamis Anthony P Transscleral drug delivery device and related methods
EP1732571A4 (en) * 2004-03-05 2009-09-09 Archemix Corp Controlled modulation of the pharmacokinetics and biodistribution of aptamer therapeutics

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995030139A1 (en) * 1994-04-29 1995-11-09 Perkin-Elmer Corporation System for real time detection of nucleic acid amplification products
US6426335B1 (en) * 1997-10-17 2002-07-30 Gilead Sciences, Inc. Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
US20020172946A1 (en) * 2000-02-07 2002-11-21 Jian-Bing Fan Nucleic acid detection methods using universal priming
EP1130113A1 (en) * 2000-02-15 2001-09-05 Johannes Petrus Schouten Multiplex ligation dependent amplification assay
EP1319718A1 (en) * 2001-12-14 2003-06-18 Keygene N.V. High throughput analysis and detection of multiple target sequences
US20040138163A1 (en) * 2002-05-29 2004-07-15 Mcswiggen James RNA interference mediated inhibition of vascular edothelial growth factor and vascular edothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LI DAO KE ET AL: "A NOVEL APPROACH TO GLIOMA GENE THERAPY: DOWN-REGULATION OF THE VASCULAR ENDOTHELIAL GROWTH FACTOR IN GLIOMA CELLS USING RIBOZYMES", INTERNATIONAL JOURNAL OF ONCOLOGY, EDITORIAL ACADEMY OF THE INTERNATIONAL JOURNAL OF ONCOLOGY,, GR, vol. 12, no. 6, June 1998 (1998-06-01), pages 1391 - 1396, XP008043063, ISSN: 1019-6439 *
ZHANG LIN ET AL: "Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 303, no. 4, 18 April 2003 (2003-04-18), pages 1169 - 1178, XP002317732, ISSN: 0006-291X *

Also Published As

Publication number Publication date
EP1776474A2 (en) 2007-04-25
US20070178476A1 (en) 2007-08-02
US7785784B2 (en) 2010-08-31
JP2008507284A (en) 2008-03-13
WO2006012468A2 (en) 2006-02-02

Similar Documents

Publication Publication Date Title
WO2006012468A3 (en) Detection of oligonuleotides by dual hybridization
MX2010002113A (en) Methods for detecting oligonucleotides.
WO2012009578A3 (en) Nanopore-facilitated single molecule detection of nucleic acids
EP1959012A3 (en) Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAs and their target mRNAs
WO2008052774A3 (en) Methods for detection of a single- or double-stranded nucleic acid molecule
WO2007136736A3 (en) Methods for nucleic acid sorting and synthesis
WO2006076674A3 (en) Deprotection and purification of oligonucleotides and their derivatives
WO2007085497A8 (en) Markers for the prediction of outcome of anthracycline treatment
WO2006029258A3 (en) Aptamer medicinal chemistry
WO2006028601A3 (en) Method for distinguishing methicillin resistant s. aureus from methicillin sensitive s. aureus in a mixed culture
WO2008061537A3 (en) Oligonucleotides for modulating target rna activity
WO2005098029A3 (en) Methods for quantification of micrornas and small interfering rnas
WO2009151546A3 (en) Methods for treating spinal muscular atrophy
JP2009502115A5 (en)
WO2006122311A3 (en) Microfluidic chip
WO2003064441A3 (en) Oligonucleotides comprising alternating segments and uses thereof
WO2003070910A3 (en) INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2006131537A3 (en) Methods for the diagnosis of immune graft tolerance
WO2009002937A3 (en) Methods for isolating long fragment rna from fixed samples
WO2008113111A8 (en) Assay for gene expression
WO2005059172A3 (en) Method and nucleic acids for the improved treatment of breast cell proliferative disorders
WO2007135568A3 (en) A METHOD FOR PREDICTING RESPONSIVENESS TO TNFα BLOCKING AGENTS
WO2007058968A3 (en) Gene expression profiles and methods of use
WO2008040355A3 (en) Novel methods for quantification of micrornas and small interfering rnas
WO2011034583A3 (en) Inhibition of endosomal toll-like receptor activation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007522778

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2005776987

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005776987

Country of ref document: EP